Los Angeles, 18 April 2026 — The Breakthrough Prize Foundation announced the 2026 laureates at a gala ceremony in Los Angeles, awarding six $3 million prizes for outstanding discoveries in Life Sciences, Fundamental Physics, and Mathematics. The total prize money this year reached $18.75 million, bringing the cumulative amount conferred over the prize's 15-year history to more than $340 million.
Popularly known as the "Oscars of Science," the Breakthrough Prize was co-founded by Sergey Brin, Priscilla Chan and Mark Zuckerberg, Julia and Yuri Milner, and Anne Wojcicki. Now in its 14th year of ceremonies, the prize celebrates scientists whose discoveries are significantly driving the growth of human knowledge.
Life Sciences: Three Prizes for Transformative Medicine
Gene Therapy for Inherited Blindness
Jean Bennett, Katherine A. High, and Albert Maguire share a Breakthrough Prize in Life Sciences for developing the first FDA-approved gene replacement therapy. Their work targets Leber congenital amaurosis, a rare inherited retinal disease that typically results in total blindness in early adulthood. The therapy replaces the defective RPE65 gene, which produces a malfunctioning version of a protein critical to the visual cycle.
The husband-and-wife team of molecular biologist Bennett and ophthalmic surgeon Maguire developed the therapy from conception through animal models — including restoring sight to Swedish Briard dogs they subsequently adopted. In 2005, High, a physician-scientist at Children's Hospital of Philadelphia, invited them to collaborate on a human trial, contributing crucial expertise in clinical gene therapy and viral vector production.
The Science Behind the First CRISPR Medicine
Stuart H. Orkin and Swee Lay Thein share a second Life Sciences prize for research that transformed sickle cell disease and beta-thalassemia from incurable to treatable conditions. Their work elucidated the mechanism driving the switch from fetal to adult hemoglobin, identifying the gene BCL11A as the master repressor that shuts down fetal hemoglobin production after birth.
Thein mapped the trait of persistent fetal hemoglobin production to chromosome 2 and identified BCL11A as the key genetic player. Orkin demonstrated that inactivating BCL11A restored fetal hemoglobin production in mice and eliminated sickle cell symptoms. His laboratory identified a specific DNA enhancer region controlling BCL11A expression exclusively in red blood cells, providing a precise therapeutic target.
The translation of these discoveries into Casgevy, the first CRISPR-based medicine approved for any disease, represented a milestone in genetic medicine. The one-time therapy edits the enhancer region in patients' own blood stem cells, offering a potentially curative treatment for conditions affecting millions worldwide.
Solving the ALS and Frontotemporal Dementia Mystery
Rosa Rademakers and Bryan Traynor independently discovered the most common genetic cause of both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Through multi-year international collaborations, their labs simultaneously identified in 2011 a mutation in the C9orf72 gene — an expansion mutation where a six-letter DNA sequence repeats hundreds to thousands of times in affected individuals.
At least two therapies targeting the C9orf72 pathway are currently undergoing clinical trials, offering hope for conditions that remain incurable.
Fundamental Physics: Precision at the Frontier
Muon g-2 Collaborations
The Breakthrough Prize in Fundamental Physics was awarded to the Muon g-2 Collaborations at CERN, Brookhaven National Laboratory, and Fermilab, for their multi-decade pursuit of a single number: the anomalous magnetic moment of the muon.
The muon, a heavy cousin of the electron, behaves like a tiny magnet whose strength is subtly affected by the "foam" of virtual particles constantly appearing and disappearing in the quantum vacuum. Measuring this effect and comparing it to theoretical predictions allows physicists to probe for unknown particles or forces beyond the Standard Model.
While the final verdict on whether the discrepancy constitutes evidence for new physics remains open, the experiment stands as a remarkable theoretical, experimental, and technological endeavour.
Special Prize: David J. Gross
A Special Breakthrough Prize in Fundamental Physics was awarded to David J. Gross for a lifetime of contributions to theoretical physics. In 1973, Gross and his graduate student Frank Wilczek (alongside David Politzer) discovered asymptotic freedom — the property that the strong nuclear force gets weaker as particles approach each other but stronger as they move apart. This explained why quarks can never be observed in isolation and enabled the development of quantum chromodynamics, the final foundation stone of the Standard Model.
Gross has also made seminal contributions to heterotic string theory and has been a leading advocate for international physics collaboration, helping establish institutes in India, China, and South America.
Mathematics: Frank Merle
Frank Merle of CY Cergy Paris Université and the Institut des Hautes Études Scientifiques received the Breakthrough Prize in Mathematics for his work on nonlinear evolution equations — the mathematical descriptions of how waves, fluids, and dynamic systems change over time.
His most remarkable result, achieved with Pierre Raphael, Igor Rodnianski, and Jérémie Szeftel, proved that the defocusing version of the nonlinear Schrödinger equation — long believed to be inherently stable — can in fact blow up in finite time. This exploited an unexpected connection to fluid dynamics and helped resolve a major open problem in the compressible Euler and Navier-Stokes equations.
Early-Career Recognition
The Foundation also recognised 15 early-career physicists and mathematicians through six $100,000 New Horizons Prizes. The inaugural Vera Rubin New Frontiers Prize was awarded to Carolina Figueiredo of Princeton University for her discovery that three apparently unrelated quantum field theories share a common geometric structure, advancing a broader program to reformulate particle physics in purely geometric terms.
Three Maryam Mirzakhani New Frontiers Prizes of $50,000 each were awarded to women mathematicians Amanda Hirschi, Anna Skorobogatova, and Mingjia Zhang for early-career contributions to symplectic topology, geometric measure theory, and the theory of Shimura varieties, respectively.
Sources
- Breakthrough Prize, "Breakthrough Prize Announces 2026 Laureates," 18 April 2026,
- PR Newswire, "Breakthrough Prize Announces 2026 Laureates," April 2026,
- The Hindu, "Breakthrough Prizes award $18.75 million to 2026 research leaders," April 2026,
- Princeton University, "Nine Princetonians win 2026 Breakthrough Prize honors," 23 April 2026,
FIRAT Editorial Board
Institutional Research Desk · Foresight Institute of Research and Translation
The collective editorial and research translation board of FIRAT, synthesising peer-reviewed evidence, policy briefs, and division milestones across our seven foundational research pillars.
%2Fwha76-overview-of-assembly-hall.tmb-1200v.jpg%3Fsfvrsn%3D5cd3d542_7&w=3840&q=75)